Objectives. We determined whether the administration time differed between seasonal intranasal live-attenuated influenza vaccine (LAIV) and seasonal injectable trivalent inactivated influenza vaccine (TIV) during Hawaii's 2009 schoollocated influenza vaccination clinics . This information is useful for public health response and allows further investigation into possible differences between the two vaccines .
Depending on the severity of an influenza season, influenza has been reported to cause approximately 200,000 hospitalizations and up to 49,000 deaths annually. [1] [2] [3] School-aged children (those aged 5-18 years) account for approximately 40% of infections during a typical influenza season, the highest among any age group. [4] [5] [6] Additionally, children amplify transmission in a community; therefore, it is logical to focus influenza vaccination efforts on this age group. 7 With this idea in mind, the Hawaii Department of Health (HDOH) implemented school-located influenza vaccination (SLIV) clinics throughout the state during 2007. 1 In February 2008, the Advisory Committee on Immunization Practices recommended that all children aged 6 months to 18 years receive annual influenza vaccination, thus offering support for providing alternatives to physician offices to accommodate the increased annual influenza vaccination target cohort. 8, 9 The HDOH "Stop Flu at School" (SFAS) campaign is a statewide program that attempts to provide students in kindergarten through eighth grade with an annual influenza vaccination. SFAS, a voluntary program, offers both seasonal intranasal live-attenuated influenza vaccine (LAIV) and injectable trivalent inactivated influenza vaccine (TIV) free to students and staff in participating schools. Vaccine doses for the period during this study were acquired by HDOH through a combination of federal programs (e.g., Vaccines for Children, Section 317) and state funds, while operational costs were secured through a combination of federal grant funds and private (e.g., vaccine manufacturers and foundations) grants and contributions.
Intranasal LAIV was licensed in the United States in 2003 for use among healthy individuals aged 2-49 years. 10 In comparison with TIV, LAIV is administered in two sites (i.e., the sprayer is inserted in one nostril, used, removed, and then reinserted into the second nostril), has a longer list of contraindications, and is a newer delivery system. 11 Recent studies suggest that LAIV can induce both mucosal and innate immunity; is more immunogenic than TIV, as it is effective after only one dose; and requires less time to elicit an antibody response. [12] [13] [14] [15] Intramuscular TIV, in use for .30 years, has fewer contraindications, is injected in one site, and can be used in all people $6 months of age, including groups at high risk (e.g., those with asthma or other chronic underlying medical conditions) who cannot receive a live-virus vaccine. 16 During the fall of 2009, the second wave of pandemic influenza A (H1N1) was sweeping through the U.S. mainland. Hawaii state public health planners were tasked with rapidly implementing programs for H1N1 vaccine delivery, and SLIV clinics were considered an important venue to accomplish this goal. 17 HDOH was in its third year of providing seasonal influenza vaccine through SFAS, and this program offered an opportunity to study logistical considerations for implementing SLIV clinics and enhance public health program planning. Additionally, given the distinctions between seasonal LAIV and seasonal TIV, we were interested in determining whether a substantial difference existed in the administration time of the two vaccines and what factors might influence a difference during the statewide 2009 SFAS campaign.
MetHoDS
We conducted a prospective cohort study during HDOH's 2009 SFAS campaign to compare mean administration times for seasonal LAIV with seasonal TIV by collecting data through videotape review of SLIV clinics. Data were collected from October 1 through November 30, 2009. Clinics were managed by HDOH public health nurses and used contract nurses, student nurses, medical reserve corps (MRC) volunteers, or military medical corps personnel to register students and administer vaccine. Vaccinators were trained to administer both types of vaccine and primarily administered one type per clinic. However, on a few occasions, some vaccinators administered both vaccines at the same clinic, and their stations were supplied accordingly to allow for administration.
Before each clinic, parents were given vaccination consent forms to complete and return one to two months prior to the start of the 2009 SFAS campaign. This time allowed HDOH staff to review forms and have adequate time for clinic planning and operations. Parents were asked to state a preference for LAIV or TIV and indicate whether their child might have possible contraindications. Vaccination stations were arranged just before the clinic start time and stocked with prefilled, single-dose LAIV intranasal sprays or prefilled, single-dose TIV injectable syringes. School staff determined the method by which students arrived at the clinic. Students initially encountered a registration area for paperwork review and then were directed to a vaccination station. After arriving at the vaccination station, the vaccinator verified a student's identity, reviewed paperwork for contraindications, explained the procedure, administered the vaccine, and then directed him or her to a predetermined holding area to wait approximately 15 minutes before returning to class. Further details of this program have been described previously. 1 We used a stratified sampling design to select schools for study enrollment. Eligible schools were public elementary or intermediate schools on Oahu, Hawaii, with a minimum enrollment of greater than one standard deviation below mean enrollment size for the stratum (minimum enrollment was 221 students for public elementary schools and 315 students for public intermediate schools). This design produced two strata-public elementary and public intermediate schools; private and charter schools were excluded. We specified the number of clinics to be videotaped and then proportionately allocated schools into each stratum. We also specified on which dates videotaping could occur on the basis of the SFAS clinic schedule. We then used a random number generator to choose each individual school to be included in the study from among all eligible on a specific date. After school selection, we contacted the clinic manager and school principal to inform them that HDOH would videotape the clinic for the study. Principals were allowed to refuse study enrollment without repercussions. When refusal occurred, a random number generator was used to choose another school for that same date. Parents had provided consent for media events that might videotape or photograph their children as part of standard school enrollment procedure. Principals used these consent forms to determine consent for this study. Every effort was made to exclude children from filming who did not have parental consent.
We collected data by using videotape review, and we attempted to collect data on all students, except when parental consent was not provided, to eliminate the effects of sampling. Immediately before a clinic started, we positioned one to two video cameras to collect data on each consented student. We informed clinic staff that videotaping was for programmatic purposes. Each clinic was videotaped in its entirety.
The total administration time was calculated as the difference between the end and start times. Timing started when a student sat down at a vaccination station or handed the vaccinator paperwork for review. Timing ended after the student received vaccine, stood up from the station, and was directed to the holding area. Administration time included verification of identification, review of contraindications, explanation of the procedure, vaccine administration, and direction to the holding area.
In addition to the total administration time, we collected data on whether the student needed additional clinic staff assistance when being vaccinated, whether the student caused a delay, and whether the vaccinator caused a delay, so that the proportion of such encounters could be compared respectively between LAIV and TIV.
We calculated mean administration times for LAIV and TIV and compared the overall difference for the two vaccine presentations. We also compared mean administration times for the first 10 students vaccinated by each vaccinator to control for clinic characteristics during the initial start-up period when vaccinators were familiarizing themselves with procedures, and for the last 10 students vaccinated by each vaccinator to control for characteristics toward the clinic end when station supplies might diminish, thereby forcing vaccinators to temporarily leave their station.
We performed a stratified, weighted cluster analysis of means and proportions using SAS ® version 9.1.3. 18 Data were weighted on the basis of the inverse probability of a student being selected to account for incomplete ascertainment in sampled schools. We considered p#0.05 to be statistically significant.
reSultS
Among 129 schools eligible for study (median enrollment 5 568 students; range: 266-1,750 students), we decided a priori to videotape 18 clinics, allocated as 15 elementary schools and three intermediate schools.
Four elementary school principals refused enrollment because of student privacy concerns. Two additional schools were selected by using the described sampling method; one principal declined to participate because of student privacy concerns, while the other agreed to enroll his school. In total, 15 (12%) schools participated, representing 4,701 students enrolled in the study (median enrollment 5 580 students; range: 323-1,450 students). We successfully ascertained vaccination time for 3,869 (82%) students. Data could not be collected for the remaining students because of parental refusal to permit videotaping their children or because of technical difficulties, including needing to change the videotape, obstructed camera view, damaged videotape, or an incompletely captured administration time. Among 3,869 administration times evaluated, 3,167 (82%) were for elementary students and 702 (18%) were for intermediate students (Figure) . No acute adverse events were reported at any of the 15 participating clinics.
The mean administration time for all students receiving LAIV was 62 seconds (range: 19-321 seconds) and for all students receiving TIV was 90 seconds (range: 32-632 seconds), for a total difference of 28 seconds (p,0.01). A significant difference in mean administration time remained among various subgroup analyses, with LAIV having a faster mean administration time than TIV. The mean LAIV administration time was faster for elementary students than for intermediate students by one second. However, the mean administration time for TIV was faster for intermediate students than for elementary students by 22 seconds (Table 1) .
To control for vaccinator characteristics, we analyzed data by vaccinator category. Contract nurses administered a majority of vaccinations for both LAIV (70%) and TIV (71%). Among all five categories (i.e., contract nurses, MRC volunteers, military medical corps personnel, public health nurses, and student nurses), LAIV administration remained faster than TIV administration (Table 1) . Even after removing the slowest group of vaccine administrators (i.e., student nurses) from the analysis, the mean administration time for LAIV continued to be 32 seconds faster than for TIV (58 vs. 90 seconds, p,0.01).
Twelve of 47 vaccinators from eight clinics administered both TIV and LAIV during the same vaccination clinic. Eleven were contract nurses and one was an MRC volunteer. Among the eight clinics, one was in an intermediate school and the remaining seven were in elementary schools. Among this group of vaccinators, the mean administration time for LAIV (61 seconds) was faster than for TIV (86 seconds, p,0.01) (data not shown).
Among all administration times, 219 (6%) instances required additional clinic staff to assist the vaccinator in administering vaccine to the student, with 215 (98%) situations occurring in elementary schools. TIV administration times comprised 199 (91%) instances; the proportion of students requiring additional clinic staff to receive TIV (8%) was greater than the proportion receiving LAIV (1%, p,0.01) ( Table 2) .
The vaccinee caused a delay in 224 (6%) administration times; 206 (92%) of these delays occurred in elementary schools. Significantly more students receiving TIV (7%) caused a delay when being administered vaccine than students receiving LAIV (3%) (p50.05) ( Table 2) . The mean administration time for LAIV was faster than for TIV among this group (LAIV 5 111 seconds; TIV 5 143 seconds; p,0.01) (data not shown).
The vaccinator caused a delay (e.g., not being prepared at his/her station, paperwork problems, or procedural questions) for 217 (6%) administration times; the majority (80%; n5173) occurred in elementary schools (Table 3) . Overall, a similar proportion of vaccinators caused a delay administering LAIV (4%) compared with TIV (7%; p50.14) ( Table 2) . The mean administration time for LAIV was still faster than for TIV by 43 seconds among this group (LAIV 5 97 seconds; TIV 5 140 seconds; p,0.01) (data not shown).
DiScuSSion
Our evaluation indicated that, compared with TIV, LAIV was faster to administer and had a lower percentage of students requiring assistance from additional clinic staff during Hawaii's 2009 SFAS campaign. The overall administration time difference was 28 seconds, with LAIV having a mean administration time of 62 seconds and TIV having a mean administration time of 90 seconds. Therefore, during a four-hour vaccination clinic, 232 students can be vaccinated with LAIV while only 160 students can be vaccinated with TIV, which is a 45% increase in throughput, assuming no contraindications to LAIV. However, these calculations assume a constant flow of students and no down time between vaccinations. A realistic estimate is likely less than this calculated throughput difference. Still, our results remained consistent even after accounting for different clinic, vaccinee, and vaccinator factors. Furthermore, LAIV continued to have a faster administration time among the group of vaccinators administering both types of vaccine during the same clinic.
Required procedures for administering the different vaccines might account for our results. For instance, when providing TIV, the vaccinator must clean the area before injection, then place a bandage over the 
Limitations
This study was subject to several limitations. For one, age appeared to be a factor affecting our results, as demonstrated by the fact that the proportion of students requiring assistance was greater in elementary schools. Additionally, among intermediate school students, TIV was faster to administer than LAIV, perhaps as a result of greater familiarity with the former method of administration. We were unable to collect grade-level data regarding each student because classes often overlapped when entering the clinic area, and ages could not be categorized further. More potentially subtle differences among age groups could not be identified by our study. Another limitation of our study was that findings represented only a sample of schools, as we were unable to film all schools participating in the 2009 SFAS campaign. However, we tried to ensure our study's validity and our ability to generalize the results through sampling design and statistical analysis. The proportion of students receiving LAIV (39%) and TIV (61%) closely followed the breakdown for the entire state (37% LAIV and 63% TIV) (Unpublished data, Hua He, 2010 May 3). Separately, this preference for TIV by children (or their parents) was notable, as it is the more painful option of the two. As stated previously, we were unable to record data for each administration 
concluSionS
The feasibility of providing LAIV or TIV during SLIV clinics has been examined in previous studies because such clinics are increasingly being viewed as viable modalities for improving uptake in the high-transmission school-aged population. 1, [19] [20] [21] [22] This feasibility was apparent during the 2009 H1N1 pandemic, as states adopted SLIVs as a principal method to administer vaccine for this age group. 17 Our findings support using SLIVs and demonstrate that LAIV is faster to administer and that a lower percentage of elementary school students required additional assistance from clinic staff. Nevertheless, each modality was administered rapidly, had few associated delays, and resulted in no reported adverse reactions. These considerations are critical, aside from the administration limitations of LAIV compared with TIV, when planning and implementing mass vaccination clinics in schools. The HDOH SFAS campaign has become an integral part of the state's influenza control program since its 2007 inception. Our study is the first to compare administration times between LAIV and TIV and provides valuable information to inform public health planners about logistical concerns involved with SLIVs. They should be encouraged that both vaccines can be administered rapidly. However, because our study demonstrated that LAIV can be administered more quickly, a clinic that uses only LAIV might be more efficient. When other considerations, such as the higher cost of LAIV and concern for contraindications with a live-virus vaccine, are lesser concerns over vaccinating as many people and as quickly as possible, then LAIV, especially now with data suggesting its greater immunologic benefit compared with TIV in the school-aged population, might be a more attractive option for an SLIV clinic. [12] [13] [14] [15] 23, 24 Individual preference as an additional obstacle aside, our findings may also provide public health planners further support to improve the acceptance of LAIV.
